Patients feel benefit as drug prices cut

    By Wang Xiaodong | China Daily | Updated: 2020-01-14 04:07
    Share
    Share - WeChat
    Li Ziyu (right), an expert at the Beijing Cancer Hospital, explains treatment to a patient in Cangzhou, Hebei province, as part of cooperation between large hospitals in Beijing and smaller ones outside of the city. [Photo/Xinhua]

    Health: Reimbursement list widens

    The negotiations resulted in the average price of drugs being reduced by just over 60 percent, according to the health administration. Agreements were also renewed for another 27 drugs already on the list, with an average price cut of 26 percent, the administration said. The expanded list took effect on Jan 1.

    These drugs have proved effective in treating cancer and other serious illnesses, such as hepatitis, diabetes, tuberculosis, and both rare and cardiovascular diseases.

    Most of the drugs have only been on the market for just two years. Their inclusion on the reimbursement list will further reduce patients' financial burden, according to the administration.

    Xiong Xianjun, head of medical services supervision at the administration, said, "The negotiations were the largest of their kind in China in recent years, resulting in many achievements, including a significant fall in drug prices.

    "Some imported drugs will be sold at the lowest prices in the world on the Chinese mainland. Coupled with reimbursement by healthcare insurance funds, it is estimated that the price drop will reduce patients' spending more than 80 percent in general, and by over 95 percent in a few cases."

    Only a few years ago, many imported patented drugs, including those to treat cancer, cost more in China than in many other countries due to factors including higher tariffs, costs incurred by middlemen and a lack of domestic competitors. There was no price negotiation system, and many of the drugs were not included in the basic healthcare insurance program for reimbursement.

    This placed a great financial burden on millions of cancer patients, with many of them having to buy cheaper generic drugs from countries such as India through the internet, posing potential health and legal risks.

    Cancer cases and other chronic illnesses such as cardiovascular disease are rising. According to the National Cancer Institute, more than 10,000 people a day in China are diagnosed with cancer due to the aging population and unhealthy lifestyles. As a result, medical bills are expected to rise rapidly in the coming years.

    Last year, Dying to Survive, a movie based on real-life events centering on the dilemma facing many leukemia patients, sparked heated public debate, with calls being made for accelerated efforts to improve patients' access to expensive patented drugs.

    |<< Previous 1 2 3 4 Next   >>|
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    亚洲一区日韩高清中文字幕亚洲| 亚洲大尺度无码专区尤物| 无码人妻丝袜在线视频| 日韩久久无码免费毛片软件| 亚洲国产精品无码久久九九 | 蜜桃无码一区二区三区| 无码人妻精品一区二| 日韩精品无码AV成人观看| 中文字幕一区二区三区永久| 中文字幕av无码专区第一页| 草草久久久无码国产专区| 无码伊人66久久大杳蕉网站谷歌| 亚洲成A人片在线观看中文| 中文字幕无码精品三级在线电影 | 成在人线AV无码免观看麻豆| 无码久久精品国产亚洲Av影片 | 无码精品人妻一区二区三区免费看| 国产欧美日韩中文字幕| 人妻少妇久久中文字幕一区二区| 无码毛片一区二区三区中文字幕| 国产精品亚洲аv无码播放| 无码久久精品国产亚洲Av影片| 亚洲中文久久精品无码| 久久午夜夜伦鲁鲁片免费无码影视| 日本一区二区三区不卡视频中文字幕| 亚洲精品成人无码中文毛片不卡| 亚洲av午夜国产精品无码中文字| 18禁免费无码无遮挡不卡网站 | 人妻丰满?V无码久久不卡| 久久无码人妻一区二区三区| 无码AV波多野结衣久久| 欧洲人妻丰满av无码久久不卡| 人妻无码αv中文字幕久久琪琪布| 亚洲AV无码片一区二区三区| 亚洲成AV人片在线观看无码| 亚洲精品无码久久久久去q | 日韩人妻无码一区二区三区综合部| 久久精品中文字幕一区| 无码任你躁久久久久久老妇App| 国产成年无码AV片在线韩国| 午夜福利av无码一区二区|